| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/10/2004 | US6689090 Perfusion apparatus and methods for pharmaceutical delivery |
| 02/10/2004 | CA2274581C Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 02/10/2004 | CA2272854C Keratinocyte growth factors and their use in combination with glucagon-like peptide derivatives |
| 02/10/2004 | CA2123430C Prohormone convertase transformed cells |
| 02/10/2004 | CA2017211C Methods for tagging and tracing materials with nucleic acids |
| 02/09/2004 | CA2842992A1 Production of thin, irregular chips with scalloped edges and surface bubbles |
| 02/09/2004 | CA2421269A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/06/2004 | CA2434356A1 Improved fluorescent resonance energy transfer probes |
| 02/05/2004 | WO2004012046A2 Method for analyzing readings of nucleic acid assays |
| 02/05/2004 | WO2004011938A2 Method and device for screening molecules in cells |
| 02/05/2004 | WO2004011681A1 Microfluidic device including purification column with excess diluent, and method |
| 02/05/2004 | WO2004011680A1 Regulated aptamer therapeutics |
| 02/05/2004 | WO2004011676A2 Multi-reporter gene model for toxicological screening |
| 02/05/2004 | WO2004011673A1 Auto-stimulating cells and method for making and using the same |
| 02/05/2004 | WO2004011670A2 Methods and compositions for nad(p)(h) oxidases |
| 02/05/2004 | WO2004011667A2 Geranyl diphosphate synthase molecules, and nucleic acid molecules encoding same |
| 02/05/2004 | WO2004011665A2 Methods for fragmentation, labeling and immobilization of nucleic acids |
| 02/05/2004 | WO2004011657A1 Method for enhancing the nutritive value of plant extract |
| 02/05/2004 | WO2004011656A1 Method for enhancing yield of recombinant protein production from plants |
| 02/05/2004 | WO2004011655A1 Marker for selecting transformant with the use of lethal gene |
| 02/05/2004 | WO2004011654A1 Novel serine protease |
| 02/05/2004 | WO2004011653A1 Novel peptide synthase gene |
| 02/05/2004 | WO2004011652A1 Process for producing tripeptide or higher peptide |
| 02/05/2004 | WO2004011651A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 02/05/2004 | WO2004011650A2 Antigens encoded by alternative reading frame from pathogenic viruses |
| 02/05/2004 | WO2004011649A1 Recombined myosin |
| 02/05/2004 | WO2004011648A2 CYTOCHROME P450s |
| 02/05/2004 | WO2004011647A1 Modified small interfering rna molecules and methods of use |
| 02/05/2004 | WO2004011646A1 Method of detecting base mutation |
| 02/05/2004 | WO2004011645A1 Mtehod of preventing nucleic acid from degradation, method of extracting nucleic acid and method of preserving nucleic acid |
| 02/05/2004 | WO2004011644A1 Method of promoting homologous recombination of somatic cells and method of constructing specific antibody |
| 02/05/2004 | WO2004011640A1 Three-dimensional structure of dipeptidyl peptidase iv |
| 02/05/2004 | WO2004011638A2 Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures |
| 02/05/2004 | WO2004011637A2 Modified adamts4 molecules and method of use thereof |
| 02/05/2004 | WO2004011636A2 Method of enzymatic deubiquitination |
| 02/05/2004 | WO2004011635A1 Genes from propionibacterium freudenreichii encoding enzymes involved in vitamin b12 biosynthesis |
| 02/05/2004 | WO2004011634A1 A novel method aimed at the generation of conbinatorial compound libraries using protoplats fusion |
| 02/05/2004 | WO2004011628A1 New mutant strains of pseudomonas fluorescens and variants thereof, methods for their production, and uses thereof in alginate production |
| 02/05/2004 | WO2004011626A2 Assays and methods based on microcompetition with a foreign polynucleotide |
| 02/05/2004 | WO2004011625A2 Polymorphisms for predicting disease and treatment outcome |
| 02/05/2004 | WO2004011624A2 Double stranded rna structures and constructs, and methods for generating and using the same |
| 02/05/2004 | WO2004011623A2 Antisense modulation of ptpra expression |
| 02/05/2004 | WO2004011615A2 USES OF CIRCADIAN GENE mPER2 |
| 02/05/2004 | WO2004011614A2 Virus induced gene silencing in plants |
| 02/05/2004 | WO2004011613A2 Composition & methods for treatment and screening |
| 02/05/2004 | WO2004011611A2 Taci antibodies and uses thereof |
| 02/05/2004 | WO2004011610A2 Antisense modulation of polo-like kinase expression |
| 02/05/2004 | WO2004011608A2 Methods and nucleic acid vectors for rapid expression and screening of cdna clones |
| 02/05/2004 | WO2004011606A2 Macromolecular protection assay |
| 02/05/2004 | WO2004011605A2 Hybrid protein methods and compositions |
| 02/05/2004 | WO2004011601A2 Corn event pv-zmir13 (mon863) plants and compositions and methods for detection thereof |
| 02/05/2004 | WO2004011596A2 Method for preparing an extracellular matrix and its use for tumor cell culture |
| 02/05/2004 | WO2004011595A2 Vectors for transferring molecules of interest in target cells |
| 02/05/2004 | WO2004011594A2 Novel method for analyzing nucleic acid and use thereof for evaluating the degree of mrna editing of the serotonin 5-ht2c receptor |
| 02/05/2004 | WO2004011592A2 Petal-array support for use with microplates |
| 02/05/2004 | WO2004011493A1 The bzip type transcription factor of corn and its coding gene and the usage thereof |
| 02/05/2004 | WO2004011492A1 Expression system |
| 02/05/2004 | WO2004011491A2 Peptidyl-trna hydrolase of enterococcus faecalis |
| 02/05/2004 | WO2004011489A2 Tropism-modified adenoviral vectors, preferably for targeting b-lymphocytes or ovarian cells |
| 02/05/2004 | WO2004011485A2 Stabilized bioactive peptides and methods of identification, synthesis, and use |
| 02/05/2004 | WO2004011401A2 Method for making biochips |
| 02/05/2004 | WO2004011142A1 Device and method for purification of nucleic acids |
| 02/05/2004 | WO2004011141A1 Size-exclusion ion-exchange particles |
| 02/05/2004 | WO2004011025A1 Plant cell wall loosening activity of group 2/3 allergens of grass pollen |
| 02/05/2004 | WO2004010959A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 02/05/2004 | WO2004010956A2 Antisense modulation of lar expression |
| 02/05/2004 | WO2004010947A2 Humanized antibodies against human 4-1bb |
| 02/05/2004 | WO2004010935A2 Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies |
| 02/05/2004 | WO2004010771A2 Nuclear transfer embryo formation method |
| 02/05/2004 | WO2004010767A2 Application of aspen mads-box genes to alter reproduction and development in trees |
| 02/05/2004 | WO2003104449A3 Improved method for protein production in plant cells |
| 02/05/2004 | WO2003100541A3 Methods for profiling molecules with an objective function |
| 02/05/2004 | WO2003099228A8 Compositions and processes for inhibiting gene expression using polynucleotides |
| 02/05/2004 | WO2003097871A3 Marker molecules associated with lung tumors |
| 02/05/2004 | WO2003097089A3 Attenuation of metapneumovirus |
| 02/05/2004 | WO2003094829A3 Pathogen vaccines and methods for using the same |
| 02/05/2004 | WO2003094828A3 Cancer vaccines and methods of using the same |
| 02/05/2004 | WO2003093501A3 Ssh based methods for identifying and isolating unique nucleic acid sequences |
| 02/05/2004 | WO2003093320A3 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses |
| 02/05/2004 | WO2003089624A3 Fc receptor homolog, reagents, and uses thereof |
| 02/05/2004 | WO2003087818A3 Diagnostic and therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signaltransduction |
| 02/05/2004 | WO2003085086A9 Motif-grafted hybrid polypeptides and uses thereof |
| 02/05/2004 | WO2003084996A3 Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine |
| 02/05/2004 | WO2003084989A3 La1 - the genome of a lactobacillus strain |
| 02/05/2004 | WO2003084560A3 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 02/05/2004 | WO2003083442A3 Life sciences business systems and methods |
| 02/05/2004 | WO2003083038A3 Disruption of the redk gene |
| 02/05/2004 | WO2003082919A3 Ox40r binding agents |
| 02/05/2004 | WO2003082255A3 Use of mob-5 in pain |
| 02/05/2004 | WO2003082195A9 Protamine-adenoviral vector complexes and methods of use |
| 02/05/2004 | WO2003079776A3 Identification of the flt1 gene required for angiogenesis in zebrafish, and uses thereof |
| 02/05/2004 | WO2003076629A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family |
| 02/05/2004 | WO2003076452A3 Temperature sensitive mutant derivatives of the broad host range plasmid pbhr1 |
| 02/05/2004 | WO2003074654A3 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 02/05/2004 | WO2003072811A3 The use of ribozymes in the detection of adventitious agents |
| 02/05/2004 | WO2003072708A3 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 02/05/2004 | WO2003070917A3 Rna interference mediated inhibition of myc and myb genes or genes of their respective pathways |
| 02/05/2004 | WO2003069341A3 Method of diagnosis of inflammatory diseases using calgranulin c |
| 02/05/2004 | WO2003066091A3 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 02/05/2004 | WO2003062384A3 Stem cell maturation for all tissue types |